Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Probiotic Yoghurts in UK Hospitals
Transcript of Probiotic Yoghurts in UK Hospitals
Wednesday, December 3, 2014
Vol XCIII, No. 311
Probiotic Yoghurts in UK hospitals
Benefits for patients and society
Antibiotic Associated Diarrhea (AAD)
Can Probiotics be used to prevent AAD and CDAD
Potential limits of probiotic use
≥60% of hospital outbreaks
Use of antibiotic
15-25% cases of AAD
Enterotoxin A and B
Clostridium difficile associated Diarrhea (CDAD)
associated Diarrhea (CDAD)
Death of 1/10 patients
Studies differ on the overall outcome.
Studies have been small single-centre trials with varying quality, providing insufficient data to reliably assess of effectiveness (Allen et al. 2013).
Potential economic advantages of these treatment modalities are currently unknown (Mergenhagen et al. 2014).
Prevention with probiotics could reduce recurrent infections (CDI).
Use of probiotics could reduce the incidence of AAD and CDAD.
Since probiotics have variable efficacy, the US FDA does not currently regulate the content (Mergenhagen et al. 2014).
The use of probiotics prevents AAD and CDAD in patients taking antibiotics
Thank you for your attention